PRESS RELEASE published on 06/19/2023 at 07:00, 3 years 1 month ago Biophytis reports clinical results for Sarconeos (BIO101) in sarcopenia treatment at the 16th SCWD International Congress
PRESS RELEASE published on 06/16/2023 at 23:00, 3 years 1 month ago Biophytis: RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023 ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTED
PRESS RELEASE published on 06/16/2023 at 23:00, 3 years 1 month ago RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE DU 16 JUIN 2023 ADOPTION DE L’ENSEMBLE DES RÉSOLUTIONS PRÉSENTÉES PAR LA SOCIÉTÉ
PRESS RELEASE published on 06/05/2023 at 08:00, 3 years 1 month ago Biophytis annonce sa participation à la BIO International Convention de Boston du 5 au 8 juin
PRESS RELEASE published on 06/05/2023 at 08:00, 3 years 1 month ago Biophytis to participate at the BIO International Convention in Boston from the 5th to the 8th of June
PRESS RELEASE published on 05/26/2023 at 08:00, 3 years 2 months ago Biophytis has filed with the French National Authority for Health (HAS) an application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the treatment of severe forms of COVID-1
PRESS RELEASE published on 05/26/2023 at 08:00, 3 years 2 months ago Biophytis a soumis à la Haute Autorité de Santé (HAS) une demande d’Autorisation d’Accès Précoce (AAP) pour Sarconeos (BIO101) dans le traitement des formes sévères de COVID-19
PRESS RELEASE published on 05/25/2023 at 08:00, 3 years 2 months ago Biophytis a présenté les résultats positifs de Phase 2-3 COVA à la Conférence internationale de l’American Thoracic Society
PRESS RELEASE published on 05/25/2023 at 08:00, 3 years 2 months ago Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
PRESS RELEASE published on 05/15/2023 at 08:00, 3 years 2 months ago Biophytis a demandé à l’EMA l’autorisation de lancer l’étude SARA-31 de phase 3 dans la sarcopénie
Published on 07/29/2026 at 19:47, 3 hours 1 minute ago Iconic Gold Announces Voluntary Delisting from TSX Venture Exchange
Published on 07/29/2026 at 15:01, 7 hours 47 minutes ago Worksport Announces Q2 2026 Earnings Call and Investor Town Hall for August 11, 2026; CEO Believes Current Market Valuation Does Not Yet Fully Reflect Recent Positive Operating Progress
Published on 07/29/2026 at 14:30, 8 hours 18 minutes ago Stabilis Solutions Announces Second Quarter 2026 Conference Call and Webcast Date
Published on 07/29/2026 at 21:45, 1 hour 2 minutes ago Piramal Pharma Limited Announces Results for Q1 FY27
Published on 07/29/2026 at 21:12, 1 hour 35 minutes ago Interim individual report for the period ending on 30.06.2026
Published on 07/29/2026 at 18:25, 4 hours 22 minutes ago International Fencing Federation prevails over Reuters in court - Court of Appeal prohibits false claims about the open letter to the IOC
Published on 07/29/2026 at 18:21, 4 hours 26 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/29/2026 at 18:07, 4 hours 40 minutes ago Quarterly Activities Report for the period ending 30 June 2026
Published on 07/29/2026 at 18:40, 4 hours 7 minutes ago Aéroports de Paris SA - Mise à disposition du rapport financier semestriel 2026
Published on 07/29/2026 at 18:40, 4 hours 7 minutes ago Aéroports de Paris SA - Availability of the 2026 financial interim report
Published on 07/29/2026 at 18:30, 4 hours 18 minutes ago Aéroports de Paris SA - Groupe ADP 2027-2034 Economic Regulation Agreement (ERA) project
Published on 07/29/2026 at 18:30, 4 hours 18 minutes ago Aéroports de Paris SA - Projet de contrat de régulation économique 2027-2034 du Groupe ADP
Published on 07/29/2026 at 18:29, 4 hours 18 minutes ago Aéroports de Paris SA - 2026 Half-year results
